Drug Shortage Report for SODIUM BICARBONATE INJECTION USP

Last updated on 2023-08-01 History

Report ID 197649 Drug Identification Number 00261971 Brand name SODIUM BICARBONATE INJECTION USP Common or Proper name SODIUM BICARBONATE INJECTION USP Company Name PFIZER CANADA ULC Market Status MARKETED Active Ingredient(s) SODIUM BICARBONATE Strength(s) 42MG Dosage form(s) SOLUTION Route of administration INTRAVENOUS INTRAVENOUS Packaging size 10 x 10mL LifeShield syringes ATC code B05XA ATC description I.V. SOLUTION ADDITIVES Reason for shortage Disruption of the manufacture of the drug. Anticipated start date Actual start date 2023-07-05 Estimated end date Unknown Actual end date Shortage status Actual shortage Updated date 2023-08-01 Company comments Health Canada comments Tier 3 Status No Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5 Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language v5

2023-08-01

French Compare v4

2023-08-01

English Compare v3

2023-07-06

English Compare v2

2023-07-05

French Compare v1

2023-07-05

English Compare

• 1

Showing 1 to 5 of 5